1219 related articles for article (PubMed ID: 24703908)
21. Biomarkers for Diabetic Retinopathy - Could Endothelin 2 Be Part of the Answer?
Binz N; Rakoczy EP; Ali Rahman IS; Vagaja NN; Lai CM
PLoS One; 2016; 11(8):e0160442. PubMed ID: 27482904
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor-A
Ved N; Hulse RP; Bestall SM; Donaldson LF; Bainbridge JW; Bates DO
Clin Sci (Lond); 2017 Jun; 131(12):1225-1243. PubMed ID: 28341661
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical Characterization of Connexin43 Expression in a Mouse Model of Diabetic Retinopathy and in Human Donor Retinas.
Mugisho OO; Green CR; Zhang J; Binz N; Acosta ML; Rakoczy E; Rupenthal ID
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186067
[TBL] [Abstract][Full Text] [Related]
24. Glucocorticoids exert differential effects on the endothelium in an in vitro model of the blood-retinal barrier.
van der Wijk AE; Canning P; van Heijningen RP; Vogels IMC; van Noorden CJF; Klaassen I; Schlingemann RO
Acta Ophthalmol; 2019 Mar; 97(2):214-224. PubMed ID: 30168271
[TBL] [Abstract][Full Text] [Related]
25. Plastic roles of pericytes in the blood-retinal barrier.
Park DY; Lee J; Kim J; Kim K; Hong S; Han S; Kubota Y; Augustin HG; Ding L; Kim JW; Kim H; He Y; Adams RH; Koh GY
Nat Commun; 2017 May; 8():15296. PubMed ID: 28508859
[TBL] [Abstract][Full Text] [Related]
26. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.
Murata T; Nakagawa K; Khalil A; Ishibashi T; Inomata H; Sueishi K
Lab Invest; 1996 Apr; 74(4):819-25. PubMed ID: 8606491
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models.
Ting KK; Zhao Y; Shen W; Coleman P; Yam M; Chan-Ling T; Li J; Moller T; Gillies M; Vadas MA; Gamble JR
Diabetologia; 2019 Feb; 62(2):322-334. PubMed ID: 30443753
[TBL] [Abstract][Full Text] [Related]
28. Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats.
Fan Y; Liu K; Wang Q; Ruan Y; Ye W; Zhang Y
Exp Eye Res; 2014 Oct; 127():104-16. PubMed ID: 24910901
[TBL] [Abstract][Full Text] [Related]
29. Diabetic macular edema: passive and active transport of fluorescein through the blood-retina barrier.
Sander B; Larsen M; Moldow B; Lund-Andersen H
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):433-8. PubMed ID: 11157879
[TBL] [Abstract][Full Text] [Related]
30. Increased Ephrin-B2 expression in pericytes contributes to retinal vascular death in rodents.
Coucha M; Barrett AC; Bailey J; Abdelghani M; Abdelsaid M
Vascul Pharmacol; 2020 Aug; 131():106761. PubMed ID: 32585189
[TBL] [Abstract][Full Text] [Related]
31. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
[TBL] [Abstract][Full Text] [Related]
32. Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy.
Lobo CL; Bernardes RC; Figueira JP; de Abreu JR; Cunha-Vaz JG
Arch Ophthalmol; 2004 Feb; 122(2):211-7. PubMed ID: 14769598
[TBL] [Abstract][Full Text] [Related]
33. Suppression of protein kinase C-ζ attenuates vascular leakage via prevention of tight junction protein decrease in diabetic retinopathy.
Song HB; Jun HO; Kim JH; Yu YS; Kim KW; Kim JH
Biochem Biophys Res Commun; 2014 Jan; 444(1):63-8. PubMed ID: 24434146
[TBL] [Abstract][Full Text] [Related]
34. The Ins2Akita mouse as a model of early retinal complications in diabetes.
Barber AJ; Antonetti DA; Kern TS; Reiter CE; Soans RS; Krady JK; Levison SW; Gardner TW; Bronson SK
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2210-8. PubMed ID: 15914643
[TBL] [Abstract][Full Text] [Related]
35. Significance of outer blood-retina barrier breakdown in diabetes and ischemia.
Xu HZ; Le YZ
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2160-4. PubMed ID: 21178141
[TBL] [Abstract][Full Text] [Related]
36. Single-cell transcriptome analysis of the Akimba mouse retina reveals cell-type-specific insights into the pathobiology of diabetic retinopathy.
Van Hove I; De Groef L; Boeckx B; Modave E; Hu TT; Beets K; Etienne I; Van Bergen T; Lambrechts D; Moons L; Feyen JHM; Porcu M
Diabetologia; 2020 Oct; 63(10):2235-2248. PubMed ID: 32734440
[TBL] [Abstract][Full Text] [Related]
37. Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Yu YS; Cho CS; Kim KW
J Cereb Blood Flow Metab; 2009 Mar; 29(3):621-8. PubMed ID: 19107135
[TBL] [Abstract][Full Text] [Related]
38. Thioredoxin-interacting protein deficiency ameliorates diabetic retinal angiogenesis.
Duan J; Du C; Shi Y; Liu D; Ma J
Int J Biochem Cell Biol; 2018 Jan; 94():61-70. PubMed ID: 29203232
[TBL] [Abstract][Full Text] [Related]
39. Effect of vascular endothelial growth factor upregulation on retinal gene expression in the Kimba mouse.
Binz N; Ali Rahman IS; Chinnery HR; McKeone R; Simpson KM; Speed TP; Lai CM; Rakoczy PE
Clin Exp Ophthalmol; 2013 Apr; 41(3):251-62. PubMed ID: 22788671
[TBL] [Abstract][Full Text] [Related]
40. Peripheral vessel leakage (PVL): a new angiographic finding in diabetic retinopathy identified with ultra wide-field fluorescein angiography.
Oliver SC; Schwartz SD
Semin Ophthalmol; 2010; 25(1-2):27-33. PubMed ID: 20507194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
